ProKidney Corp. (PROK) — Strategic Asset Allocation Index
ProKidney Corp. (PROK) has a Strategic Asset Allocation Index of 3.9% as of June 2023. Strategic assets (PP&E of $17.68 Million plus long-term investments of $-) total $17.68 Million, measured against net assets of $456.94 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is ProKidney Corp.'s balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
ProKidney Corp. Strategic Asset Allocation Index (2019–2022)
This chart shows how ProKidney Corp.'s Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 3.9%, representing strategic assets of $17.68 Million against net assets of $456.94 Million USD. For live market cap and overall valuation, see PROK stock market capitalisation.
Annual Strategic Asset Allocation Index for ProKidney Corp. (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for ProKidney Corp. from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See ProKidney Corp. (PROK) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 2.1% | $10.71 Million | $10.71 Million | $- | $504.94 Million | ▼ -44.7 pp |
| 2021 | 46.8% | $12.60 Million | $12.60 Million | $- | $26.92 Million | ▼ -59.4 pp |
| 2020 | 106.2% | $10.47 Million | $10.47 Million | $- | $9.86 Million | ▲ +85.2 pp |
| 2019 | 20.9% | $3.33 Million | $3.33 Million | $- | $15.88 Million | — |